Evan R. Goldfischer, MD, MBA, CPI, CPE, Co-Founding CEO and Founding Director of Research for Premier Medical Group of the Hudson Valley, and Secretary of LUGPA, updates his presentation from earlier this year detailing how to effectively manage a clinical research program. He examines why clinical research is important and how it has changed over the years, noting that the biggest changes in 2020 include more training, more paperwork, and more time and difficulty negotiating budgets. Dr. Goldfischer also looks at how to obtain trials and highlights the need to network to do this successfully. He discusses integrating the research program with the cancer clinic, as well as how the staff must work together to ensure a program’s success. He also covers the importance of getting physicians engaged in the research, as well as managing budgets and patient recruitment. The main takeaway is that clinical research must involve everyone in the practice in order to be a well-managed program.
Q&A – Summary:
In this follow-up interview with E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology, Dr. Goldfischer discusses the effects of COVID-19 on managing these programs, such as possible relaxation of FDA protocols for research programs, including virtual visits and shipping back leftover drugs, and the possible carryover of these rule changes after the pandemic is under control.
How to cite: Goldfischer, Evan R. “Managing a Clinical Research Program in 2020 (Updated)” July 2020. Accessed Oct 2020. https://grandroundsinurology.com/managing-a-clinical-research-program-in-2020-updated/